sGCalphal inhibiting compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 5, 2016
Issued Date -
N/A
app pub date -
Nov 1, 2013
filing date -
May 30, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides materials and methods useful to treat various sGCα1-expressing cancers. Materials include peptides which interfere with sGCα1's pro-survival functions, thereby resulting in apoptosis of sGCα1-expressing cells. In addition, the present invention provides screening assays, diagnostic assays, methods to prognose, methods to treat, and kits.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully